Clinical Trial Update: EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

The EWOC-1 Phase 2 trial evaluating carboplatin with or without paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED